natural glp 1 receptor agonists GLP-1 Agonist Services for Type 2 Diabetes and Obesity Drug Development America's Poison Centers - GLP-1
Description
After 12 to 18 months, some patients may even be able to stop the GLP-1 drug and use FIM programming for weight maintenance
Not ideal for a drug that should be taken continuously, because the pounds pile back on quickly
465 Impaired GLP-1 secretion or reduced GLP-1R expression may result in aberrantly heightened sympathetic excitation
GCG glucagon
95% CI, 1.01-1.68)
Reduced incretin effect in type 2 diabetes
